Company intelligence / Profile preview

Clarity China Partners

Hong Kong, Hong Kong

Ownership: Private
Development stage: Other

Overview

Clarity China is a private equity and venture capital firm that specializes in growth-stage investments within the Greater China region. The firm maintains a significant focus on the healthcare sector, targeting high-growth opportunities in medical devices, healthcare services, and pharmaceutical distribution. Clarity China provides strategic capital and operational guidance to help its portfolio companies scale and improve efficiency. The firm is known for its hands-on investment approach and has a track record of successful exits, including the acquisition of its portfolio company Kanghui Medical by Medtronic. Its leadership team consists of experienced investment professionals with deep expertise in the Chinese market and international finance.

Industry: Investors

Beyond the preview

Go deeper on Clarity China Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clarity China Partners.

Explore the full profile